Comprehensive Digestive Stool Analysis in Ottawa
Digestive complaints like bloating, gas, diarrhea and or constipation are among the most common in medical care. The health of the gut is related to overall health including:
- Mood: 90% of serotonin (“happy & sleep hormone”) production is found in the gut
- Immunity: 70% of your immune system is found in the gut
- Weight: those who gain weight easily have a reduced variety of microbiome (ecosystem of microbes found in an on the body) and are of a different combination of microbes compared to those who don’t gain weight easily
- Sleep: the gut produces the neurotransmitter melatonin which helps you sleep and is an antioxidant
- Pain: those who have increased pain also have a different microbial balance than those who don’t have pain.
This comprehensive stool analysis helps to determine the causes of gastrointestinal symptoms and chronic systemic conditions, and measures key markers of digestion, microbial imbalances or infection, absorption and inflammation.
- Highlight: Digestive Health Stool Test- Microbes, Health of Digestive System, Quality of Digestion & Immunity
- Your Key Symptoms: Bloating, Gas, Pain, Diarrhea, Constipation; Autoimmune Conditions, Fatigue, Difficulty Losing Weight, Multiple Food Reactions, Anxiety, Depression, Learning Disorders
- Why Test? The gut and the microbiome may be linked to up to 90 percent of all disease.
- Indicated For: Those with digestive concerns and overall wellness
- Results Available: Generally, in 2 weeks once the lab has received your sample.
What is the test available for comprehensive digestion at Revivelife Clinic?
- Comprehensive Stool Analysis (CSAP) with Parasitology
What are the common symptoms & conditions associated with digestive dysfunction?
- Autoimmune Disease – Rheumatoid Arthritis, Celiac, Chron’s, Ulcerative Colitis, Diabetes, Muscular Dystrophy, Multiple Sclerosis, Thyroid
- Bacterial & Parasitic Infections
- Brain Health – ADD – Attention Deficit Disorder, Autism, Dementia, Alzheimer’s Disease
- Digestion – Chronic and Acute Gastroenteritis, IBD – Inﬂammatory Bowel Disease, IBS – Irritable Bowel Syndrome
- Fungal or Yeast Infections
- Heart Disease
- Immunity – Asthma, Allergies
- Intestinal Permeability/ Leaky Bowel Syndrome
- Mood – Anxiety, Depression
- Parkinson’s Disease
- SIBO – Small Intestinal Bacterial Overgrowth
- Skin Conditions – Acne, Eczema, Psoriasis, Rosacea
- Suspected H. pylori Infection
- Viral Pathogens
- Weight Management
As most health conditions relate to the microbiome (ecosystem of microbes) in your body, 70% of immunity and 90% of serotonin production (your “happy & sleep” hormone) anyone wanting to optimize their health can benefit from this test.
How is digestive dysfunction treated?
Your Revivelife clinician will review all findings and create a tailored plan to you based on what are the root causes of your digestive dysfunction. The use of tailored probiotics, prebiotics, anti-inflammatories, nutrients, stress management and or acupuncture that promote healing are often advised. Additional testing including food sensitivities, SIBO (small intestinal bacterial overgrowth) and or an organic acid test may be considered to further investigate the potential causes of increased GI concerns.
We recommend a New Patient Visit for the most comprehensive approach to your health or a Pre-Lab Visit for a quick snapshot before lab testing and a Post-Lab consult to review your results and receive your tailored health plan.
To Book, an Appointment Click Here or Call 613-829-7100
LEARN MORE – coming soon!
The Comprehensive Stool Analysis (CDA) with Parasitology x1, 2, or 3 is an invaluable non-invasive diagnostic assessment that permits health professionals to objectively evaluate the status of beneficial and imbalanced commensal bacteria, pathogenic bacteria, yeast/fungus and parasites. Precise identification of pathogenic species and susceptibility testing greatly facilitates selection of the most appropriate pharmaceutical or natural treatment agents. The CDA-DD uses the MALDI-TOF (matrix assisted laser desorption/ionization time-of-flight mass spectrometry) which can help identify over 1,200 species of bacteria and yeast and is also used by NASA.
Using growth-based culture, the standard of practice in clinical microbiology, as well as sensitive biochemical assays and microscopy, this thorough profile evaluates the status of beneficial and pathogenic microorganisms including aerobic and anaerobic bacteria, yeast and parasites. Antimicrobial susceptibility testing to prescriptive and natural agents is also performed for appropriate bacterial and fungal species at no additional charge. Parasitology testing can include one-, two- or three-day collection, based on practitioner preference.
- Microbial Screening: for friendly bacteria and unfriendly bacteria, fungi, yeast, ova & parasites and worms. Includes screening for Giardia, Cryptosporidium, Clostridium difficile, Aeromonas, Campylobacter, Plesiomonas, Salmonella, Shigella, Vibrio, Yersinia, & Edwardsiella tarda
- Health of The Small & Large Intestinal Lining (Irritation & Inflammation): Lactoferrin, Calprotectin, Lysozyme, WBCs , Mucus, occult blood & pH are tested to determine digestive inflammation.
- Digestion: Elastase, Fat Stain, Muscle Fibre, Vegetable Fibres, Carbohydrates are tested to assess how well the body is actually breaking down foods including fats, proteins and carbohydrates.
- Short Chain Fatty Acids: Butyrate,fSHFAs
- Pancreatic Digestive Strength: Chymotrypsin
- Immunity: sIgA
This test is a very thorough investigation of the overall quality of the digestive system that may be an underlying roadblock to other health conditions including disease.
Important information regarding the efficiency of digestion and absorption can be gleaned from the measurement of the fecal levels of elastase (pancreatic exocrine sufficiency), fat, muscle and vegetable fibers, and carbohydrates. Inflammation can significantly increase intestinal permeability and compromise assimilation of nutrients. The extent of inflammation, whether caused by pathogens or inflammatory bowel disease (IBD), can be assessed and monitored by examination of the levels of biomarkers such as lysozyme, lactoferrin, white blood cells and mucus. These markers can be used to differentiate between inflammation associated with potentially life-threatening inflammatory bowel disease (IBD), which requires lifelong treatment, and less severe inflammation that can be associated with irritable bowel syndrome (IBS) which is frequently due to the presence of enteroinvasive pathogens. Lactoferrin is only markedly elevated prior to and during the active phases of IBD, but not with IBS. Monitoring fecal lactoferrin levels in patients with IBD can therefore facilitate timely treatment of IBD, and the test can be ordered separately. Since the vast majority of secretory IgA (sIgA) is normally present in the GI tract, where it prevents binding of pathogens and antigens to the mucosal membrane, it is essential to know the status of sIgA in the gut. sIgA is the only bona fide marker of humoral immune status in the GI tract.
Cornerstones of good health include proper digestion of food, assimilation of nutrients, exclusion of pathogens and timely elimination of waste. To obtain benefits from food that is consumed, nutrients must be appropriately digested and then efficiently absorbed into portal circulation. Microbes, larger-sized particles of fiber, and undigested foodstuffs should remain within the intestinal lumen. Poor digestion and malabsorption of vital nutrients can contribute to degenerative diseases, compromised immune status and nutritional deficiencies. Impairment of the highly specific nutrient uptake processes, or compromised GI barrier function, as in “leaky gut syndrome,” can result from a number of causes including:
- Low gastric acid production
- Chronic maldigestion
- Food allergen impact on bowel absorptive surfaces
- Bacterial overgrowth or imbalances (dysbiosis)
- Pathogenic bacteria, yeast or parasites and related toxic irritants
- The use of NSAIDs and antibiotics
Impairment of intestinal functions can contribute to the development of food allergies, systemic illnesses, autoimmune disease, and toxic overload from substances that are usually kept in the confines of the bowel for elimination. Efficient remediation of GI dysfunctions incorporates a comprehensive guided approach that should include consideration of elimination of pathogens and exposure to irritants, supplementation of hydrochloric acid, pancreatic enzymes and pre- and probiotics, and repair of the mucosal barrier.
Information Courtesy Of: Doctor’s Data Lab
What are the risks of developing digestive dysfunction?
The principal risks of developing digestive dysfunction include:
- Genetic Link
- Poor Diet – standard American diet, which is low in fibre and high in sugar and saturated fats
- Excess Alcohol
- Stress – reducing the good microbiome and digestive enzymes
- Aging – reduction of digestive enzymes
- Medication Use – antibiotics, NSAIDs
How do you know if your digestive system is working properly?
The seven most common signs that your digestion is not working properly include:
- Upset stomach – gas, bloating, constipation, diarrhea and or heartburn
- A poor menu – refined foods, high sugar-diet and over indulgences in coffee, tea or other processed beverages
- Unintentional weight changes
- Sleep disturbances or constant fatigue
- Skin irritations – acne, eczema, psoriasis or rosacea
- Autoimmune conditions – celiac, diabetes, rheumatoid arthritis
- Food intolerances, sensitivities or allergies
How many times a day is optimal for bowel movements?
The optimal is one bowel movement after each meal – the realistic goal is at least one bowel movement a day.
How long does digestion take?
Digestion varies in individuals and between men and women. After eating it generally takes about six to eight hours for food to pass through your stomach and small intestine. Food then enters your large intestine (colon) for further digestion, absorption of water and then finally elimination of undigested food. Mayo clinic researchers found that the average time from eating to elimination of stool averaged 53 hours (which may be overstated, as the markers used by the researchers passed more slowly that the actual food ingested). Men tend to digest at a faster rate than women.
What are digestive enzymes?
Digestive enzymes are released by your body to help you break down the foods that you eat. Here is a list of common digestive enzymes and their functions.
|Key Digestive Enzymes and Their Functions|
|Pepsin||Secreted by cells in the stomach lining; in combination with stomach acid, it helps break down proteins into peptides in the stomach|
|Trypsin||Originating in the pancreas and the intestinal lining, trypsin is secreted into the duodenum (the upper portion of the small intestine), where it breaks down peptides formed in the stomach into amino acids|
|Chymotrypsin||A digestive enzyme originating in the pancreas and the intestinal lining, it is activated by the action of trypsin and helps break down protein|
|Proteases||Secreted by the pancreas, they facilitate the breakdown of proteins into amino acids|
|Amylase||Present in saliva, and also secreted by the pancreas, it cleaves complex carbohydrate molecules into manageable sugars|
|Lipase||Present in saliva, and also secreted by the pancreas, it facilitates breakdown of lipids (fats) into useable components|
|Lactase||Secreted by cells lining the small intestine, it helps break down lactose (milk sugar)|
|Papain (from papaya)||Supplements help protein digestion|
|Cellulase||Produced by “friendly” bacteria in the gut, it helps digest cellulose and other plant constituents|
Enzyme table courtesy of Life Extension.
How do I know if my stomach pain is serious?
Any of the following are signs of potentially serious digestive conditions and follow up with your medical team and or emergency are recommended.
- Signs of bleeding
- Intense pain
- A sudden pain in the lower part of the abdomen may be signs of appendicitis. It may also be accompanied by a fever.
Why do I feel bloated often?
Bloating is often caused by excess gas production or disturbances in the movement of the muscles of the digestive system. Bloating can often cause pain, discomfort or cause your stomach to look bigger. In many cases there is an underlying imbalance of the GI system which may include SIBO (small intestinal bacterial overgrowth), food intolerances, sensitivities or allergies and or disturbances in the digestive microbiome.
What helps digestion after eating?
A few simple tips to promote digestion include:
- Enjoying mint or chamomile tea after dining
- Avoiding processed foods
- Relaxing while dining
- Eat fruit between meals instead of with meals
- Avoid overeating or too close to bedtime
Step 1- Patient Preparation
- Schedule Your Pre-Lab Consult and receive the at home test kit with directions.
- Please read all of the directions, and familiarize yourself with the collection procedures.
- 4 Weeks Prior: Food Intolerances: Consume your normal menu including dietary fat (to properly assess fat absorption). If you have been avoiding any food intolerances discuss with your practitioner if a return to consumption of these foods is indicated for proper test results.
- 2 Weeks Prior: Probiotic Supplements: Discontinue use unless otherwise instructed by your physician
- 3 Days Prior: Anti-fungal or Antibiotic Medication: Finish the course of medication and then wait 3 days before starting this test.
- 2 Days Prior: Digestive Enzymes, Laxatives, Antacids, Aspirin & Barium or Bismuth containing medications: Discontinue use for 2 days prior to testing.
- Never discontinue prescription medications or natural remedies that would make you feel unwell without first consulting your physician.
Step 2- The Comprehensive Stool Analysis Test
- Please follow the instructions provided in your test kit.
Step 3- Shipping
- Next follow the directions to ship the test kit to the lab. Ship Monday – Wednesday for best results. Keep a record of the shipping number and email it to the clinic so that we can track your test results.
Note- Please refer to test kit and if any variation exists between the information here and your test kit, follow your test kit instructions. Additional information is provided in the test kits regarding preparation, collection and medications, circumstances, medical conditions, supplements, etc. that may affect the results of the test.
- Terry, N, and Gross Margolis, K, Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance, Handb Exp Pharmacol. 2017; 239: 319–342. , PMID: 28035530
- Vighi, G, et al, Allergy and the gastrointestinal system, Clin Exp Immunol. 2008 Sep; 153(Suppl 1): 3–6. , PMID: 18721321
- Wu, H-J, and Wu, Eric, The role of gut microbiota in immune homeostasis and autoimmunity, Gut Microbes. 2012 Jan 1; 3(1): 4–14., PMID: 22356853
- Wilders-Truschnig, M et al, IgG Antibodies Against Food Antigens are Correlated with Inflammation and Intima Media Thickness in Obese Juveniles, Exp Clin Endocrinol Diabetes 2008; 116(4): 241-245, DOI: 10.1055/s-2007-993165
- Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. 2013 Aug 29;500(7464):541–6. PubMed PMID: 23985870.
- Chen, C-Q, et al, Distribution, function and physiological role of melatonin in the lower gut, World J Gastroenterol. 2011 Sep 14; 17(34): 3888–3898., PMID: 22025877
- Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. 2013;2:e01202. PubMed PMID: 24192039. Pubmed Central PMCID: 3816614.
- Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013 Jun 6;498(7452):99–103. PubMed PMID: 23719380. [PubMed] [Google Scholar]
- Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell host & microbe. 2014 Mar 12;15(3):382–92. PubMed PMID: 24629344. Pubmed Central PMCID: 4059512. Using a large cohort of new-onset, treatment-naive pediatric Crohn’s disease patients, this case-control study describes early CD-associated features of the intestinal microbiome. The finding that rectal, but not fecal, microbiota differentiated CD and healthy patients may have diagnostic implications. [PMC free article] [PubMed] [Google Scholar]
- Haberman Y, Tickle TL, Dexheimer PJ, et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. The Journal of clinical investigation. 2014 Aug 1;124(8):3617–33. PubMed PMID: 25003194. Pubmed Central PMCID: 4109533. In a large case-control study of new-onset, treatment-naive IBD pediatric patients, the authors identify patterns of ileal host gene expression and ileal microbiome that are unique to CD patients irrespective of the presence of ileal inflammation. These data on early changes in the microbiota and host response may support the hypothesis that dysbiosis contributes to the development of IBD in susceptible individuals. [PMC free article] [PubMed] [Google Scholar]
- Toro-Londono, Miguel, et al, Intestinal parasitic infection alters bacterial gut microbiota in children, PeerJ. 2019; 7: e6200. , PMID: 30643702
- Kowalski, K and Mula, A, Brain-Gut Axis in Alzheimer’s Disease, J Neurogastroenterol Motil. 2019 Jan; 25(1): 48–60., PMID: 30646475, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326209/
- Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe. 2013 Aug 14;14(2):207–15. PubMed PMID: 23954159. Pubmed Central PMCID: 3772512. [PMC free article] [PubMed] [Google Scholar]
- Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014 Jan;146(1):67–75. e5. PubMed PMID: 24076059. PubMed] [Google Scholar]
- Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014 May;146(6):1489–99. PubMed PMID: 24560869. Pubmed Central PMCID: 4034132. [PMC free article] [PubMed] [Google Scholar]
- Benner, M, et al, How uterine microbiota might be responsible for a receptive, fertile endometrium, Hum Reprod Update. 2018 Jul 1;24(4):393-415,, PMID: 29668899 https://www.ncbi.nlm.nih.gov/pubmed/29668899
- Amir Minerbi, Emmanuel Gonzalez, Nicholas J.B. Brereton, Abraham Anjarkouchian, Ken Dewar, Mary-Ann Fitzcharles, Stéphanie Chevalier, Yoram Shir. Altered microbiome composition in individuals with fibromyalgia. PAIN, 2019; 1 DOI: 10.1097/j.pain.0000000000001640
- Kabir, MA, and Ahmad, Z, Candida Infections and Their Prevention, ISRN Prev Med. 2013; 2013: 763628., PMID: 24977092
- Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011 Apr 7;472(7341):57–63. PubMed PMID: 21475195. Pubmed Central PMCID: 3086762. [PMC free article] [PubMed] [Google Scholar]
- Frati, F. et al, The Role of the Microbiome in Asthma: The Gut–Lung Axis, Int J Mol Sci. 2019 Jan; 20(1): 123. , PMID: 30598019,
- Kelly, JR, et al, Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders, Front Cell Neurosci. 2015; 9: 392. , PMID: 26528128, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604320/
- Lubomski, M, et al, Parkinson’s disease and the gastrointestinal microbiome, J Neurol. 2019 Apr 30. PMID: 31041582, https://www.ncbi.nlm.nih.gov/pubmed/31041582
- Adike, A and DiBaise, JK, Small Intestinal Bacterial Overgrowth: Nutritional Implications, Diagnosis, and Management, Gastroenterol Clin North Am. 2018 Mar;47(1):193-208., PMID: 29413012
- Salem, I, et al, The Gut Microbiome as a Major Regulator of the Gut-Skin Axis, Front Microbiol. 2018; 9: 1459. , PMID: 30042740, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048199/
- Pereira-Marques, J, et al, Helicobacter pylori Infection, the Gastric Microbiome and Gastric Cancer., Adv Exp Med Biol. 2019 Apr 24., PMID: 31016631, https://www.ncbi.nlm.nih.gov/pubmed/31016631
- Robinson, CM and Pfeiffer, J, Viruses and the Microbiota, Annu Rev Virol. 2014; 1: 55–69. , PMID: 25821837, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373533/
- Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013 Aug 29;500(7464):541–6. PubMed PMID: 23985870. [PubMed] [Google Scholar]